GeneDx Holdings Corp. Increase (Decrease) in Other Operating Assets and Liabilities, Net
GeneDx Holdings Corp. (WGS) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $20.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-03
- GeneDx Holdings Corp. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was $10.90M, a 9.28% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was $9.13M.
- GeneDx Holdings Corp. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was -$10.14M.
- GeneDx Holdings Corp. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$10.72M.
- GeneDx Holdings Corp. increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was -$11.97M.
- GeneDx Holdings Corp. increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$3.54M, a 716.35% decline from fiscal 2023.
- GeneDx Holdings Corp. increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was $575.00K, a 93.20% decline from fiscal 2022.
- GeneDx Holdings Corp. increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was $8.46M.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $20.02M 10-Q · filed 2026-08-03 | $9.88M derived: sum of 3 quarters · filed 2026-08-03 | -$843.00K derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | $9.13M 10-Q · filed 2026-05-04 | -$1.02M derived: sum of 2 quarters · filed 2026-05-04 | -$11.74M derived: sum of 3 quarters · filed 2026-05-04 | $271.00K derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | -$10.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$20.86M derived: sum of 2 quarters · filed 2026-02-23 | -$8.85M derived: sum of 3 quarters · filed 2026-08-03 | -$11.97M 10-K · filed 2026-02-23 | |||
| 2025-09-30 | -$10.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.29M derived: sum of 2 quarters · filed 2026-08-03 | -$1.83M 10-Q · filed 2025-10-28 | -$6.57M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | $12.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $8.89M 10-Q · filed 2026-08-03 | $4.15M derived: sum of 3 quarters · filed 2026-08-03 | $23.00K derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | -$3.12M 10-Q · filed 2026-05-04 | -$7.86M derived: sum of 2 quarters · filed 2026-05-04 | -$11.99M derived: sum of 3 quarters · filed 2026-05-04 | -$10.95M derived: sum of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | -$4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$8.87M derived: sum of 2 quarters · filed 2026-02-23 | -$7.84M derived: sum of 3 quarters · filed 2026-02-23 | -$3.54M 10-K · filed 2026-02-23 | -$3.72M 10-K · filed 2025-02-20 | ||
| 2024-09-30 | -$4.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$3.10M derived: sum of 2 quarters · filed 2025-10-28 | $1.20M 10-Q · filed 2025-10-28 | $399.00K derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $5.33M 10-Q · filed 2025-07-29 | $6.09M 10-Q · filed 2024-07-30 | $4.53M derived: sum of 3 quarters · filed 2026-02-23 | $6.43M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-03-31 | $4.29M 10-Q · filed 2025-04-30 | $3.50M derived: sum of 2 quarters · filed 2026-02-23 | $5.40M derived: sum of 3 quarters · filed 2026-02-23 | $2.08M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2023-12-31 | -$797.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.11M derived: sum of 2 quarters · filed 2026-02-23 | -$2.21M derived: sum of 3 quarters · filed 2026-02-23 | $575.00K 10-K · filed 2026-02-23 | $2.53M 10-K · filed 2024-02-23 | ||
| 2023-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$1.42M derived: sum of 2 quarters · filed 2024-10-29 | $1.37M 10-Q · filed 2024-10-29 | $1.37M 10-Q · filed 2023-11-03 | $1.21M derived: sum of 4 quarters · filed 2024-10-29 | ||
| 2023-06-30 | -$3.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$531.00K 10-Q · filed 2024-07-30 | -$694.00K derived: sum of 3 quarters · filed 2024-07-30 | ||||
| 2023-03-31 | $2.79M 10-Q · filed 2024-04-29 | $2.63M derived: sum of 2 quarters · filed 2024-04-29 | |||||
| 2022-12-31 | -$163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $8.46M 10-K · filed 2024-02-23 | |||||
| 2022-09-30 | $8.62M 10-Q · filed 2023-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |